InterOcean Capital Group’s Immix Biopharma IMMX Stock Holding History

InterOcean Capital Group’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$36.5K	Hold	11,900	–	–	﹤0.01%	477
2023 Q4	$82.3K	Sell	11,900 -4,000	-25%	-$18.1K	﹤0.01%	456
2023 Q3	$54.4K	Hold	15,900	–	–	﹤0.01%	438
2023 Q2	$42.8K	Hold	15,900	–	–	﹤0.01%	440
2023 Q1	$28.9K	Hold	15,900	–	–	﹤0.01%	409
2022 Q4	$36.4K	Hold	15,900	–	–	﹤0.01%	397
2022 Q3	$22K	Hold	15,900	–	–	﹤0.01%	407
2022 Q2	$41K	Hold	15,900	–	–	﹤0.01%	415
2022 Q1	$38K	Buy	+15,900	New	+$59K	﹤0.01%	283

Other funds holding IMMX

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CCM

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

InterOcean Capital Group's IMMX Position: Q1 2024 in Review

InterOcean Capital Group held its Immix Biopharma (IMMX) position steady in Q1 2024 at 11,900 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

InterOcean Capital Group first reported a position in IMMX in Q1 2022 and has held it in 9 quarters since. The position peaked at $82.3K in Q4 2023. 35 funds tracked by Wall St. Rank hold IMMX as of Q1 2024.

InterOcean Capital Group held 11,900 shares of Immix Biopharma worth $36.5K as of Q1 2024.
InterOcean Capital Group left its Immix Biopharma share count unchanged in Q1 2024.
Immix Biopharma made up ﹤0.01% of InterOcean Capital Group's portfolio in Q1 2024, its #477 holding.
InterOcean Capital Group first reported a position in Immix Biopharma in Q1 2022 and has held it in 9 quarters since.
InterOcean Capital Group's Immix Biopharma position peaked at $82.3K in Q4 2023.
35 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.